Introduction
Apoptotic programmed cell death is required for the normal elimination of cells during development and provides an important mechanism to destroy those cells whose growth regulation has been usurped by viral infection or activated oncogenes. Though exceptions exist, cell death pathways typically involve mitochondrial disruption, either as a primary stimulus or as an ampli®er of downstream events, including activation of a caspase cascade (for reviews see Budihardjo et al., 1999; Hengartner, 2000; Korsmeyer et al., 2000; Krammer, 2000) . These core mitochondrial events, including release of cytochrome c and corresponding activation of initiator caspase-9, are linked to a plethora of upstream intrinsic and extrinsic death stimuli. Emerging evidence, however, argues that it is the BCL-2 family of death regulators that ultimately integrates these pathways, by coupling upstream death signals to events at the surface of the organelle. In the absence of a death stimulus, pro-apoptotic BCL-2 members, including BH-3 only BID, BAD, and BIM, exist as inactive entities in the cytoplasm. In response to a death trigger, one or more of the BH-3 only proteins become active, induce changes in BAX and BAK in the mitochondrial outer membrane, and initiate mitochondrial apoptotic pathways (see Korsmeyer et al., 2000; Huang and Strasser, 2000; Wei et al., , 2001 Zong et al., 2001) . Anti-apoptotic BCL-2 members on the other hand are constitutively located in the mitochondrial outer membrane and, when present in excess, can counter these mitochondrial death pathways in most instances (Gross et al., 1999) . In addition to their location in mitochondria, however, anti-apoptotic BCL-2 proteins are also present in the endoplasmic reticulum (ER)/nuclear envelope (Krajewski et al., 1993; Akao et al., 1994; Nguyen et al., 1994) , suggesting that the ER, like the mitochondrion, is an important site for regulating cell death. To date, several such ER regulators have been proposed, including the BAP31 complex (Ng et al., 1997; Ng and Shore, 1998; Nguyen et al., 2000) , presenilins (Aberici et al., 1999; Passer et al., 1999) , RTN-XS (Tagami et al., 2000) and an ER-regulated murine caspase, caspase-12 (Nakagawa et al., 2000) .
Among intrinsic inducers of apoptosis, expression of activated oncogenes like cellular MYC and adenovirus E1A potently stimulates downstream processing of caspases and, therefore, these oncogene products depend on inactivation of the death machinery to manifest cell transformation (White, 1996; Breckenridge and Shore, 2000; Jun and Evan, 2000) . Suppression of apoptosis can be achieved in several ways, including upregulation of anti-apoptotic BCL-2 members or inactivation of p53, which otherwise is responsible for stimulating the downstream pathways of cell death in these contexts. In cells with wild type p53, E1A and MYC stimulate p19
arf -mediated inhibition of MDM2 and this in turn leads to stabilization and elevation of p53 levels (Lowe, 1999; Prives and Hall, 1999; Verma et al., 2001) , resulting in major changes in p53-regulated gene expression. Recently, a number of these gene targets of p53 have been identi®ed as inducers of apoptosis. They include KILLER/DR5 (Wu et al., 1997) , BAX (Miyashita and Reed, 1995) , Noxa (Oda et al., 2000b) , PERP (Attardi et al., 2000) , p53AIP1 (Oda et al., 2000a) , PIDD (Lin et al., 2000) , and Puma (Yu et al., 2001; Nakamo and Vousden, 2001) . BAX, Noxa, Puma, and p53AIP1 all target mitochondria to induce cell death. Thus, p53 leads to induction of multiple pro-apoptotic eector molecules, several of which execute their toxic eects by in¯uencing mitochondrial integrity.
Here, we employed a DNA microarray analysis of E1A-responsive gene products as a ®rst step to identify pro-apoptotic BIK/NBK as a downstream eector of E1A-and p53-mediated cell death. BIK/NBK was originally identi®ed as a binding partner and antagonist of anti-apoptotic BCL-2 and its adenovirus homolog, E1B 19K, and is a canonical and founding member of the BH-3 only family of BCL-2 proteins (Boyd et al., 1995; Han et al., 1996) . Like BH-3 only BIM and members of the BCL-2 and BAX subfamilies, BIK contains a predicted transmembrane segment at its extreme COOH-terminus (Boyd et al., 1995; Han et al., 1996) . As noted, most BH3 only proteins studied to date are suggested to exert their in¯uence at the level of mitochondria. We show here, however, that a signi®cant amount of both ectopically expressed as well as endogenous BIK localizes to the ER, a site where BCL-2 is also present.
Results
The products of early region 1A of adenovirus, 12S E1A and 13S E1A mRNA, encode proteins that stimulate DNA synthesis and cell proliferation or, depending on cellular context, apoptosis. In contrast to the 289 amino acid product of 13S E1A mRNA, the shorter 243-residue product of 12S E1A, which lacks conserved region 3 (CR3), is incapable of activating other early viral transcriptional units. Thus, virus that produces 12S E1A and that lacks the E1B region, whose 19 kDa and 55 kDa protein products are inhibitors of apoptosis, is a vector that eciently delivers 12S E1A as the main vector expression product. The resulting 243 residue E1A protein is a potent inducer of apoptosis in a wide variety of cells, for which it exhibits a strong dependence on wild type p53 (Debbas and White, 1993; Lowe and Ruley, 1993) . BCL-2 or E1B 19K protects cells against 243R E1A-induced apoptosis (Nguyen et al., 1994; Rao et al., 1992) by inhibiting activation of caspases (Boulakia et al., 1996; Sabbatini et al., 1997) . Figure 1a describes the time course for induction of cell death after infecting a human KB epithelial cell line with Ad5 dl520E1B, which expresses only 12S E1A and no E1B products (Shepherd et al., 1993) . As previously documented in these cells, death is by apoptosis and involves release of cytochrome c from mitochondria and activation of initiator caspases -8 and -9 and eector caspase-3, all of which are blocked in the presence of ectopic BCL-2 (Boulakia et al., 1996; Nguyen et al., 1998) . The 243R E1A protein was maximally expressed by 24 h and then declined. p53, on the other hand, was undetectable in these cells in the absence of E1A expression, but increased through to 48 h in response to E1A (Figure 1b) . The E1A-induced increase in p53 was unaected by excess BCL-2 (Figure 1d ).
E1A responsive genes
To investigate the changes in host cell gene expression in response to E1A, KB cells were infected for 40 h with the 12S E1A expression vector, Ad4 dl520E1B, or mock infected, and total cellular mRNA was isolated and puri®ed. Biotin-labeled cRNA was prepared from each sample and used to screen the Aymetrix DNA microarray chip, HuGeneFL GeneChip, which harbors 5600 cDNA probes encoding known proteins. Quanti®cation of the dierential signals arising from the two cRNA population identi®ed 393 individual KB gene transcripts whose levels changed by twofold or greater in response to E1A expression ( Figure 1c ). Among this group were BIK and FAS, whose GeneChip signal levels increased 3-and 8.4-fold, respectively.
E1A induces BIK protein in KB epithelial cells
In Figure 1d , total cell extracts from KB cells or from KB cells stably expressing HA-BCL-2 were prepared at various times after delivery of the Ad5 dl520E1B E1A expression vector, and the extract proteins analysed by SDS ± PAGE and immunoblotting with the indicated antibodies. As expected (Vousden, 2000) , FAS protein increased but signi®cant changes in this protein occurred only late in response to E1A. BIK protein, on the other hand, remained undetectable in KB cells in the absence of BCL-2, but a rapid and dramatic E1A-induced increase was observed in cells expressing BCL-2. Similarly, a pcDNA3 plasmid vector encoding 12S E1A as the sole expression product also induced BIK protein in these cells (not shown), con®rming that E1A alone can trigger BIK expression. Failure to observe BIK induction in the absence of BCL-2 may result from BIK being degraded or its on-going synthesis blocked during the ensuing apoptosis, preventing its observable accumulation in the total cell population. By inhibiting apoptosis (Figure 1a ), BCL-2 overcomes these constraints on BIK accumulation, permitting its detection by immunoblotting. Consistent with this interpretation, when human H1299 cells were transiently transfected with cDNAs encoding either wt HA-BIK or HA-BIK harboring a disabling L61G BH-3 point mutation (Figure 2a) , the mutant BIK protein but not wt BIK was subsequently detected by immunoblotting ( Figure 2b ). If transfection was conducted in the presence of the pan caspase inhibitor, zVAD-fmk, however, both proteins accumulated to similar levels. Despite the fact that wt BIK accumulated to only low levels in these cells in the absence of caspase inhibitor, it was highly toxic as judged by a survival assay employing a luciferase reporter (Ng et al., 1997) (Figure 2c ). We conclude, therefore, that E1A induces BIK protein, whose subsequent cytotoxicity may interfere with BIK accumulation. (7) HA-BCL-2. Cells were infected for the indicated times with adenovirus type 5 dl520E1B (expressing only 12S E1A mRNA and no E1B products), and the percentage of cells that were viable at each time point was determined by the ability to exclude Trypan blue. Shown are the averages and standard deviations of three independent measurements. (b) Whole cell lysates were prepared at the indicated times and aliquots containing equal amounts of protein were subjected to SDS ± PAGE and immunoblotted with anti-E1A, anti-p53 and anti-g-actin antibodies. (c) DNA microarray analysis of changes in KB cell RNA transcript levels following expression of 12S E1A. Shown is a histogram recording the number of genes whose transcripts exhibited a change equal to or greater than a twofold increase (induction) or decrease (repression). (d) Induction of BIK protein. KB epithelial cells either expressing (+) or not expressing (7) HA-BCL-2 were infected with adenovirus type 5 dl520E1B and, at the indicated times, equivalent amounts of total cell protein were resolved by SDS ± PAGE and immunoblotted with antibodies (a) against BIK, p53, FAS, g-actin, and hemagglutinin (HA)
Induction of BIK by p53
Since E1A requires p53 activation to induce apoptosis, the ability of p53 on its own to stimulate BIK expression was examined. Infection of p53-null H1299 cells with adenovirus vector expressing wt p53 resulted in rapid accumulation of p53 protein by 12 h post-infection ( Figure 3c ) followed by cell death by apoptosis (data not shown) commencing at about 20 h (Figure 3a) . BIK protein was induced and detectable in these H1299 cells in response to p53 (Figure 3c ), but levels were signi®cantly elevated in cells also expressing BCL-2, consistent with the ®ndings for KB cells expressing E1A (Figure 1 ). BCL-2 delayed but did not fully protect H1299 cells against p53. Since BIK can interact with and antagonize BCL-2 (Boyd et al., 1995; Han et al., 1996) , this may re¯ect the changing ratio of heterodimerizing pro-apoptotic BIK and anti-apoptotic BCL-2, leading to excess BIK during the time course After 16 h, cell extracts were prepared and aliquots containing equivalent amounts of protein were resolved by SDS ± PAGE and immunoblotted with antibodies against HA and g-actin. (c) BIK induces cytotoxicity. As in (b) except that transfection of BIK plasmids was conducted in combination with a luciferase reporter plasmid. Luciferase speci®c activity was measured in cell lysates and the enzyme activity expressed relative to the values obtained with co-transfection of the luciferase plasmid and an empty vector of p53 expression, which then overcomes the protective eect of BCL-2. Of note, p53 expression resulted in a dramatic increase in BIK mRNA (Figure 3b ). In the absence of p53, BIK mRNA (a) , except that at the indicated times, RNA was extracted from cells and 30 mg separated by agarose gel electrophoresis, transferred to nylon membrane, hybridized with a 32 P-labeled BIK cDNA probe, and the membrane exposed to radioautography. Shown in the bottom panel is a photograph of the ethidium bromide stained agarose gel prior to membrane transfer. The bands corresponding to 26S and 18S ribosomal RNA are indicated and provide gel loading controls. (c) Following infection of the indicated cell lines with Ad p53 vector, equivalent amounts of total cell protein were subjected to SDS ± PAGE and immunoblotting with antibodies against BIK, p53, and g-actin. (d) As in (c), instead using antibodies against BIK and p21 WAF1 for immunoblotting. (e) As in (c) except that infection was with adenovirus type 5 dl520E1B (expressing only 12S E1A mRNA and no E1B products) and the blot probed with anti-BIK antibody. Lane C (control): a sample from BIK-expressing cells was barely detectable by Northern blot analysis, whereas strong signals were observed with the Adp53 vector. Again, the presence of BCL-2 resulted in higher accumulated levels of RNA. p53 and BIK proteins appeared early in Ad p53 infected H1299 cells (Figure 3b ) and before the onset of cell death (Figure 3a) , with kinetics of appearance of BIK only slightly slower than that of p53-induced p21 WAF1 (Figure 3d) , the product of a rapid p53 responsive gene.
In accord with E1A's dependence on p53 to stimulate apoptosis, E1A expression did not cause cell death in p53-null H1299 cells (data not shown) and no detectable induction of BIK could be observed, even in the presence of BCL-2 (Figure 3e ). These results together with those in Figure 1 are consistent with E1A being a physiological stimulus of p53, which in turn induces BIK RNA and protein.
BIK protein induces caspase-dependent cell death
To assess the ability of BIK protein alone to initiate apoptosis in the absence of upstream stimuli conferred by E1A and p53, adenovirus vectors were created that express either wt HA-BIK or the mutant, HA-BIK(L61G), which contains the disabling point mutation in the BIK BH-3 domain. To construct Ad vector encoding cytotoxic BIK, virus packaging and propagation were conducted in 293T cells in which the promoter driving BIK expression was conditionally repressed (see Materials and methods). When delivered into KB epithelial cells, transcriptionally active Ad vector expressing HA-BIK caused cell death whereas Ad HA-BIK(L61G) did not, exhibiting eects indistinguishable from the control vector, Ad LacZ ( Figure 4a ). As expected from earlier transient expression studies (Boyd et al., Han et al., 1996; Elangovan and Chinnadurai, 1997; Hedge et al., 1998; Orth and Dixit, 1997) , induction of cell death by BIK in these cells was apoptotic and associated with cleavage of the caspase substrate poly(ADP-ribosyl) polymerase (PARP) (Figure 4b) . BCL-2, at the levels expressed in these cells, retarded but did not ablate the cytotoxic in¯uence of BIK. Again, the extent of BCL-2 inhibition may re¯ect the changing ratio of BIK-BCL-2 protein levels during the time course of BIK expression, with elevated BIK overcoming protection by BCL-2. Ad HA-BIK but not Ad HA-BIK(L61G) also stimulated apoptotic cell death in p53-null H1299 cells, which was strongly inhibited by the pan caspase inhibitor, zVAD-fmk (Figure 4c ). zVAD-fmk-inhibitable cleavage of the caspase targets PARP and BAP31 was also observed (not shown), consistent with BIK expression causing apoptosis by activating caspases. BIK, therefore, can replace the requirement for wt p53 in inducing apoptosis in these p53-null cells.
Elevated BIK overcomes protection by BCL-2 in E1A expressing cells
Emerging models based on gene deletion suggest that BCL-2 is a negative regulator of BAX/BAK death eectors, with BH-3 only proteins modulating these opposing functions (e.g., see Zong et al., 2001) . KB cells stably expressing elevated BCL-2 strongly resisted E1A-induced cell death despite the fact that BIK accumulated in these cells (Figure 1 ). If BIK levels were further augmented by combining Ad E1A and Ad HA-BIK infection of these BCl-2-expressing cells, however, cell death was reinstated ( Figure 5 ). These results argue that the ratio of BIK and BCL-2 in E1A-expressing cells determines cell survival or death.
Subcellular distribution of BIK
KB epithelial cells were transfected with plasmid encoding Flag-BIK in the presence of zVAD-fmk.
The cellular distribution of the BIK protein was then examined by double-label confocal immuno¯uores-cence microscopy using antibodies against Flag and either the ER marker protein, calnexin, or the outer mitochondrial membrane marker, TOM20. Representative images are shown in Figure 6 . In cells expressing Flag-BIK (Figure 6a, red) , a strong colocalization with calnexin was observed (Figure 6a,  upper panel, green) . When the anti-Flag and anticalnexin images in the same cell were merged (yellow), a co-distribution involving an extensive reticular network was observed. This apparent ER distribution of BIK clearly extended outside the location of mitochondria in these cells, as visualized by costaining of Flag-BIK (red) and the mitochondrial outer membrane marker, TOM20 (green) (Figure 6a , lower panel), con®rming that a signi®cant amount of BIK is located in the ER. In Figure 6b , biochemical fractionation was used to examine endogenous BIK in the total population of H1299 cells infected with Ad p53, again in the presence of zVAD-fmk to inhibit apoptosis and preserve cellular integrity. The endogenous BIK protein induced by p53 in the absence of apoptosis exhibited a marked co-distribution with calnexin, as visualized by immunoblotting. Additionally, BIK was detected in heavy membranes enriched in mitochondria containing TOM20, but this fraction also contained ER calnexin.
Discussion
Recent evidence has suggested that pro-apoptotic BH-3 only members of the BCL-2 family couple upstream death signals to downstream activation of BAX and BAK, resulting in cell death Wei et al., 2001) ; anti-apoptotic BCL-2 and BCL-X L in excess can intercede and prevent activation of the BAX/BAK death eectors Zong et al., 2001) . One way in which upstream death signals can activate BH-3 only death stimulators is by causing structural changes in the pre-existing protein . Another is by induction of the active BH-3 only protein itself. To date, a number of gene targets have been identi®ed that are regulated by p53 and result in induction of pro-apoptotic proteins, of which Noxa and Puma appear to qualify as BH-3-only members (Oda et al., 2000b; Yu et al., 2001; Nakamo and Vousden, 2001 ). Here, we have identi®ed another canonical member of this BH-3 only family, BIK/ NBK, as a downstream target and eector in the E1A-induced p53 cell death pathway.
E1A expression typically leads to accumulation and activation of p53 in wild type cells, resulting in apoptosis. In contrast, this E1A-induced cell death is abrogated in a p53-null background (Debbas and White, 1993; Lowe and Ruley 1993) . Activation of p53 is accomplished through an obligate E1A-dependent increase in p19 arf mRNA and protein (Lowe, 1999; Vousden, 2000) . p19
arf forms a complex Figure 5 Elevated BIK expression overcomes protection from cell death by BCL-2. KB cells or KB cells stably expressing BCL-2 were infected with adenovirus expressing HA-BIK, rtTa (vector) or adenovirus type 5 dl520E1B (expressing only 12S E1A mRNA and no E1B products) as indicated. Cells were collected at the indicated time points and viability assessed via the Trypan blue exclusion with p53 and inhibits MDM2, an E3 ubiquitin protein ligase that mediates p53 degradation, resulting in induction of p53 levels and activity (Vousden, 2000; Ljungman, 2000) . Here, we show that expression of E1A in human KB epithelial cells resulted in the accumulation of p53, induction of BIK, and cell death (Figure 1 ). BCL-2 functioned downstream of p53 and BIK induction by E1A and restricted E1A-initiated apoptosis, with the ratio of BCL-2 and BIK determining death or survival in these E1A expressing cells. The proapoptotic in¯uences of E1A were abrogated in p53-null H1299 cells, but induction of both BIK mRNA and protein could be re-instated upon introduction of wt p53 into these cells, causing cell death (Figure 3) . Moreover, BIK alone induced caspase-dependent death in H1299 cells in the absence Earlier studies, as well as those described here, have shown that BIK and its predicted mouse counterpart, Blk, induce apoptosis by activating caspases (Hedge et al., 1998; Orth and Dixit, 1997) . This might be explained in part by the ability of BIK to bind to and inactivate anti-apoptotic members of the BCL-2 family (or vice versa) dependent on the BIK BH-3 domain (Boyd et al., 1995; Han et al., 1996) , although mutagenesis of BIK at regions outside the BH-3 domain can also be disabling (Elangovan and Chinnadurai, 1997) . Additionally, evidence implicating a role for control of BIK function by phosphorylation has recently been obtained (Verma et al., 2001) , and the fact that BIK may rapidly turnover during apoptosis suggests yet another level of control via BIK degradation (Marshansky et al., 2001) . It may be therefore that regulation of BIK mRNA and protein levels, as well as BIK phosphorylation and BIK turnover, provide multiple means to regulate this protein, perhaps dependent on cellular context, p53 status, and the nature of the upstream death stimulus. Although BIK mRNA levels were clearly up-regulated by p53 (Figure 3b) , we have not detected a direct stimulation of the BIK promoter by p53. Genomic sequence analysis identi®ed several elements that exhibit homology to potential but degenerate p53 response elements lying within 71700 upstream of the start site of transcription and within the long 13 kb intron 1 of the BIK gene. Analysis of these elements in the context of both homologous and heterologous promoter reporter assays, however, failed to elicit a p53 response whereas responses from the BAX and MDM2 promoters were readily detectable in the same assay (data not shown). It is possible, therefore, that p53 indirectly in¯uences BIK gene expression or RNA stability.
Finally, BIK, like BCL-2, contains a predicted transmembrane segment at its extreme C-terminus and, unexpectedly, our results suggest a signi®cant distribution of BIK at the endoplasmic reticulum, in addition to a possible location in mitochondria. The latter is consistent with the ability of recombinant BIK protein to stimulate cytochrome c release when added to a heavy membrane fraction in vitro (Shimizu and Tsujimoto, 2000) . In the ER, BIK was resistant to alkaline extraction (not shown), indicative of a membrane integrated location (Goping et al., 1998) . A number of apoptotic signaling pathways operate through the ER, and the ER is a documented site of location of BCL-2 (Krajewski et al., 1993; Akao et al., 1994; Nguyen et al., 1994) . Targeting of BIK to the ER, therefore, could allow this BH-3 only protein to antagonize BCL-2 (or vice versa) present in this membrane or perhaps permit BIK to in¯uence other ER regulators.
Materials and methods

Cells and adenovirus vectors
Stable human KB oral epithelial and H1299 lung carcinoma cell lines, either expressing or not expressing ectopic HA-BCL-2 (Nguyen et al., 1994) were cultured in a a-MEM medium supplemented with 10% fetal bovine serum and 100 mg/ml streptomycin and penicillin. Cells were harvested by incubating in phosphate buered saline (PBS) containing 1.3 mM Na citrate and 0.6 mM EDTA for 5 min at 378C, collecting the cells by centrifugation at 1000 g for 5 min, followed by a single wash of the cell pellet in PBS. Cell viability was assessed by the ability to exclude trypan blue. Infection with adenovirus type 5 dl520E1B (expressing only 12S E1A mRNA and no E1B products) or with adenovirus vector expressing human wt p53 was performed at 100 PFU/ cell, as previously described (Nguyen et al., 1994; Querido et al., 1997) . To construct a shuttle vector for production of Ad virus encoding cytotoxic BIK proteins, pCA14, a CMV promoter-containing variant of pE1sp1A (Bett et al., 1994) was digested with BglII to remove the promoter, cloning cassette and polyA signal. In its place was inserted a PCR fragment containing the TetR-repressible T-REx promoter from pcDNA4/TO followed by a multi-cloning cassette and the SV40 polyA signal to produce pCA14T-REx. cDNAs encoding HA-BIK and HA-BIK(L61G) were cloned into pCA14T-REx for virus rescues. To construct the cell line for virus rescues, 293T cells that were selected for a¯at morphology and good contact inhibition were stably transfected with pcDNA6/TR (Invitrogen), which expresses the tetR under the control of the CMV promoter. Blasticidinresistant clones were selected based on their retention of a favourable morphology and their ability to keep a reporter TREx promoter silent. The resulting cell line has been termed 293T-TR. The BIK-containing variants of the pCA14T-REx vector were introduced into 293T-TR cells using Lipofectamine Plus (GIBCO BRL) together with pJM17 (McGrory et al., 1988) , the adenoviral genomic construct. After recombination in the cells, the virus was produced with the T-RExdriven (but silent) BIK cDNAs in place of the E1 region of the virus. Virus plaques were screened by PCR for the presence of the correct insert, plaque puri®ed again, then propagated in 293T-TR cells. Virus preparations were made from freeze/thaw lysates and titrations conducted on this same cell line.
Genechip microarray analysis
KB cells were either mock infected or infected with adenovirus type 5 dl520E1B. After 40 h, the cells were collected and mRNA was extracted using a Qiagen mRNA Oligotex Direct mRNA Midi kit (Qiagen, Mississauga, ON, Canada) as directed by the manufacturer. RNA was precipitated after incubation at 7208C for 1 h in 2.5 volumes of ethanol containing 0.3 M NaAc, pH 5.2. Synthesis of double-stranded cDNA was conducted using the SuperScript Choice System kit (GIBCO) and the T7-(dT) 24 oligomer 5 '-GGCCAGTGAATTGTAATACGACTCACTATAGGG-AGGCGG ± (dT) 24 -3', as instructed by the manufacturer. An equal volume of phenol : chloroform : isoamyl alcohol, saturated with 10 mM Tris-HCL pH 8.0/1 mM EDTA, was added to the cDNA followed by aqueous phase isolation using the Phase Lock Gel system (Epperdorf). One mg of cDNA was transcribed in the presence of biotin-modi®ed ribonucleotides with the ENZO RNA transcript Labeling Kit (ENZO Diagnostics, Farmingdale, NY, USA), and unincorporated NTPs were subsequently removed using a QIAGEN RNeasy kit (Qiagen, Mississauga, ON, Canada). The biotinylated mRNA was then precipitated, resuspended in DEPC-treated water, and its concentration determined. The biotin-labeled RNAs from mock infected and infected cells were then used to screen two Aymetrix HuGeneFL GeneChip microarrays, each containing 5600 dierent human cDNA probes. The screening was performed by Research Genetics (Huntsville, AL, USA) according to standard in house procedures, and the data analysed and sorted using Microarray Suite 4.0 from Aymetrix, and quanti®ed using the Fold Change software.
Antibodies and immunoblots
The following antibodies were utilized: mouse anti-HA (Babco, Richmond, CA, USA) and ant-Flag (Sigma), rabbit anti-g actin (gift from P Braun), mouse monoclonal anti-Fas (PharMingen International), mouse monoclonal anti-p53 (PharMingen), goat polyclonal anti-BIK (Santa-Cruz Biotechnology, CA, USA), rabbit polyclonal anti-p21 (SantaCruz Biotechnology, CA, USA) mouse monoclonal anti-PARP, and rabbit anti-calnexin (gift from J Bergeron). Rabbit polyclonal antibody against human TOM20 was generated exactly as described by Goping et al. (1988) . Fluorescent Texas Red and Alexa 488 conjugated secondary antibodies were purchased from Molecular Probes (Eugene, OR, USA). For immunoblot analysis, aliquots of cell extracts containing equivalent amounts of protein were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS ± PAGE), transferred to nitrocellulose and the blots incubated with primary antibody. Blots were then incubated with secondary antibody conjugated to horseradish peroxidase, and visualized by enhanced chemiluminescence. When required, nitrocellulose blots were stripped of antibodies by incubation in 2% SDS, 100 mM b-mercaptoethanol, and 62.5 mM Tris, pH 6.8, for 30 min at 508C.
BIK cDNA and mutagenesis
BIK cDNA was cloned by reverse transcription PCR using KB cell mRNA and PCR primers derived from the BIK RNA sequence (GeneBank Accession NM_001197). The 5' sense primer contained a sequence encoding an HA epitope tag, which preceded the BIK coding region. The primers used were 5'-CACCATGTACCCATACGATGTTCCAGATTAC-GCTTCTGAAGTAAGACCCCTCTCC-3' and 5'-TCACT-TGAGCAGCAGGTGCAG-3'. An analogous procedure was used to create Flag-BIK. Standard PCR site directed mutagenesis was performed to convert BIK codon 61 from Leu to Gly using the above primers in addition to 5'-CGCATTGGCCCTGCGGGGCGCCTGCATCGGGGAC-3' and 5'-GTCCCCGATCCAGGCGCCCCGCAGGGCCAATG-CG-3' PCR fragments were cloned into pCR 2.1 TOPO cloning vector (Invitrogen, Carlsbad, CA, USA) and recombinant plasmids introduced into E. coli XL1. Authenticity and insert orientation of puri®ed plasmid (GIBCO BRL, Gaithersburg, MD, USA) were con®rmed by DNA sequencing. Constructs were digested with BamHI and EcoRV and the released BIK fragment ligated within the BamHI and EcoRV sites of PC14 T-Rex.
Transient transfections
H1299 cells were grown to approximately 60% con¯uency in 6-well cell culture dishes. 0.8 mg of PCA14 T-Rex plasmids encoding HA-BIK or HA-BIK(L61G), with or without 0.2 mg Rc/RSV plasmid encoding luciferase, were transfected using Lipofectamine Plus Reagent (GIBCO BRL, Gaithersburg, MD, USA) according to the manufacturer's instruction. zVAD-fmk (50 mM ®nal concentration) (Enzyme System Products, Dublin, CA, USA) or vehicle alone were added to appropriate samples 3 h later. Cells were collected after 20 h and extracts analysed.
Northern blots
Total RNA was collected from H1299 cells using TRIzol Reagent, as directed by the manufacturer (GIBCO BRL, Gaithersburg, MD, USA). RNA was quantitated by optical density and 30 mg used for Northern analysis. The probe was generated by digesting 6 mg of the HA-BIK.pCR 2.1 plasmid with EcoRI and XhoI. The released HA-BIK cDNA insert was resolved on a 1% agarose gel, the fragment isolated, puri®ed and labeled using an Oligolabeling Kit 9 (Amersham Pharmacia Biotech, Piscataway, NJ, USA) in the presence of a 32 P-dCTP, according to the manufacturer's protocol.
Immunofluorescence KB cells were grown to a con¯uency of 80% in 12-well dishes and transfected with vector encoding Flag-BIK. After 20 h the cells were resuspended in 1 ml PBS and 50 ml aliquots centrifuged onto coverslips for 1 min at 2000 g, in a CytoTek centrifuge (Sakura). The recovered cells were then ®xed and analysed by double-label immuno¯uorescence. Cells were visualized with a Zeiss 510 confocal microscope and images captured and overlaid with the accompanying software.
Cell fractionation
After H1299 cells had reached 60% con¯uency in a 150 mm cell culture dish, the culture medium was replaced with fresh medium containing 50 mM zVAD-fmk and 100 PFU/cell Adp53. After 20 h, the cells were collected, washed once with PBS, and resuspended in 500 ml of modi®ed HIM buer (200 mM mannitol, 70 mM sucrose, 10 mM HEPES-KOH). Cells were then homogenized with 50 strokes in a motorized Te¯on-glass homogenizer operating at 2000 r.p.m., and centrifuged at 1000 g for 10 min (all subsequent centrifugation steps were performed for 10 min each). The supernatant was centrifuged at 9000 g and the resulting pellet fraction resuspended in 500 ml of HIM, centrifuged at 1000 g, and the supernatant re-centrifuged at 9000 g to yield the heavy membrane (HM) fraction. The supernatant from the ®rst 9000 g centrifugation was centrifuged at 100 000 g, the pellet resuspended in 400 ml of HIM, and re-centrifuged at 100 000 g to pellet the light membrane (LM) fraction. The combined S-100 supernatants were then subjected to extended centrifugation at 100 000 g to generate the very light membrane (vLM) fraction. Membrane pellets were suspended to a ®nal volume of 400 ml HIM and equal aliquot volumes analysed by immunoblotting with the indicated antibodies.
